FDA Inspection 1100456 — Nalamachu, Dr Srinivas
The FDA completed an inspection of Nalamachu, Dr Srinivas on July 30, 2019 in Overland Park, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 30, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Overland Park, KS (United States)
Additional Details
Sponsor-Investigator (S-I)